Barely Significant

Excerpts

3,685 sentences · 1 filter applied

However, even if our results about efficacy are significant, we acknowledge that our study displays limitations, including the small number of patients in the compared groups with 12 patients in the “matched therapy group”, and 25 in the “non-matched therapy group”, and the imbalance of characteristics between these groups with a strong trend for more patients with PC in the first one (83%) than in the second one (44%).
Although not statistically significant, our data show a positive trend with the use of the different therapeutic regimens in terms of CR increase (64.5% with GnRHa + LNG-IUD versus 80.0% with MA+LNG-IUD and 83.3% with MA + LNG-IUD + MET), and a negative trend in terms of SD evidence (25.8% with GnRHa + LNG-IUD versus 15.0% with MA + LNG-IUD and 8.3% with MA + LNG-IUD + MET).
Among these, the retrospective analysis of the phase 3 study KEYNOTE042 indicated a clear trend towards better OS in the KRAS MUT group when comparing first-line ICB versus platinum-containing chemotherapy (28 vs. 11 months) than for the patients with KRAS WT (15 vs. 12 months) [ 45 ], albeit only 301 out of 782 patients were molecularly assessed for KRAS status, among which 69 KRAS MUT cases were identified.